> The Global Rethinkers > Life sciences innovation

Life sciences innovation

The life sciences and pharmaceutical industries have incredible potential for the future of humankind. We work with many leading figures, and our lawyers are at the cutting edge in supporting our clients.

get in touch

Dr Bea Bakshi

Super-charging the fight against cancer, Dr Bea Bakshi set up C the Signs to use the power of data to diagnose cancer at its earliest stages, when it can be treated more successfully. Working on the frontline in UK hospitals, Bea repeatedly saw the heart-breaking impact of late diagnosis. In our FT interview series, Bea talks candidly about her experience and how, alongside co-founder Dr Miles Payling, they are helping patients beat cancer.
FT interview | Bea Bakshi

1 September 2021 | Podcast

How can you successfully use innovation to fight a social mission?

29 June 2021 | Podcast

CEO and founder of Breegi Scientific, Dr. Wisam Breegi, talks faith, life changing experiences and containing coronavirus

8 June 2021 | Podcast

Founder and CEO of Antengene, Dr. Jay Mei, talks innovation in biotech, passion and learning from our mistakes

Partnering for success: charities at the forefront of scientific innovation

Find Out More

The new Charities Bill: endowment changes and opportunities in science innovation

Find Out More

Can agritech really transform the future of food?

Find Out More

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing RNA interference therapeutics that 'silences' Messenger RNAs implicated in the cause of diseases. Alnylam delivered the world's first approved RNAi therapeutic treatment in 2018 and has developed three other first-in-class RNAi-based medicines.

Omega Therapeutics

Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenetic mRNA medicines designed to controllably modulate gene expression to treat or cure diseases.

Fulcrum Therapeutics

Fulcrum Therapeutics specialises in developing treatments for genetic diseases that are largely overlooked by mainstream medicine. By adapting gene expression, disorders can be treated at their root cause.

Medovate

Medovate works collaboratively with clinical innovators and the NHS to develop, manufacture and bring to market new medical devices to improve patient safety and care.

Kynos Therapeutics

Kynos Therapeutics is developing an innovative portfolio of first-in-class medicines where there is an unmet medical need for new therapies. Their medicines block the action of KMO - a key enzyme at the interface of inflammation, immunity and metabolism.

Global Access Dx (GADx)

GADx is a leading developer and manufacturer of advanced lateral flow and rapid diagnostic technologies. Leveraging their core technology platforms, they work with governments and international organisations, reinvesting their profits to deliver high quality and affordable diagnostics.